English
Spanish
French
Italian
German
NEWS
Latest News
Advanced Antibiotic Strategies in Hidradenitis Suppurativa
May 22, 2026
In this Medscape podcast, expert clinicians discuss the real‑world challenges of caring for patients with hidradenitis suppurativa—covering timely diagnosis, evolving treatment strategies, and the importance of addressing quality‑of‑life burdens. The conversation offers practical insights to help clinicians improve outcomes and support patients over the long term.
Read more
Bimekizumab Shows Durable Responses in Psoriasis and HS Through 3 Years
May 18, 2026
New long‑term data presented at the 2026 AAD Annual Meeting suggest bimekizumab delivers durable disease control in hidradenitis suppurativa, with a growing proportion of patients remaining flare‑free through 3 years and no new safety signals observed. In this brief interview, Steven Daveluy, MD, discusses why extended assessment periods matter in HS, how sustained response influences treatment confidence, and what these findings may mean for long‑term patient care.
Read more
HS Care Has Outgrown Its Standards. The Field Is Catching Up.
May 18, 2026
HS care is evolving—and fast. This article with HS Foundation CEO, Brent Hazelett, explores how traditional standards are struggling to keep up with the realities of hidradenitis suppurativa, and why new, more patient-centered approaches are finally gaining traction. Discover what’s changing, what still needs improvement, and how the field is beginning to close the gap between outdated guidelines and real-world care.
Read more
Advancing Hidradenitis Suppurativa Care: Expert Perspectives on Diagnosis, Treatment, and Patient Impact
May 16, 2026
In this Dermatology Times video series, board-certified dermatologists Dr. Jennifer Hsiao and Dr. Barry Resnik take a comprehensive look at Hidradenitis Suppurativa—from the multidimensional burden and diagnostic challenges to evolving therapies like JAK inhibitors. Through expert insights and practical guidance, this series equips dermatologists to recognize HS earlier, address misconceptions, build patient trust, and improve long-term outcomes.
Read more
Hidradenitis Suppurativa Explained: From Pain and Stigma to Promising New Treatments
May 13, 2026
What exactly is Hidradenitis Suppurativa (HS), and why is it so often misunderstood? On this episode of Science of Skin, dermatologist Dr. Ted Lain and HS expert Dr. Steve Daveluy unpack the biology, burden, and breakthrough therapies shaping the future of HS care.
Read more
New Hope for Adolescents with Hidradenitis Suppurativa
May 11, 2026
A new chapter in care for teens with hidradenitis suppurativa is emerging. With the FDA approval of an additional biologic option, dermatologists now have greater flexibility to intervene earlier, tailor treatment, and potentially prevent lifelong scarring and disease progression. Experts explain why timing matters, how treatment strategies are evolving, and what this milestone could mean for young patients and their families—read on to explore the promise behind this breakthrough.
Read more
Avalo Therapeutics Reports Positive Phase 2 Results for Abdakibart in Hidradenitis Suppurativa
May 7, 2026
Avalo Therapeutics announced positive topline results from its Phase 2 LOTUS clinical trial evaluating abdakibart (AVTX‑009) in adults with moderate to severe hidradenitis suppurativa, supporting continued development toward a Phase 3 program.
Read more
Managing the Psychological Toll of HS
April 24, 2026
Living with hidradenitis suppurativa can take a serious emotional toll—from anxiety and depression to challenges with self-esteem, relationships, and daily life. This article explores why mental health support is a critical part of HS care and offers insight into recognizing, addressing, and treating the psychological burden of the disease. Click to read why caring for your mind matters as much as caring for your skin.
Read more
Understanding Hidradenitis Suppurativa: What You Need to Know
April 24, 2026
Painful lumps, flare-ups in skin folds, delayed diagnosis—hidradenitis suppurativa can be confusing, frustrating, and life-altering. This patient-friendly FAQ explains what HS is (and what it isn’t), who is at risk, why it’s so often misdiagnosed, and what treatment options are available. Click to learn the essential facts every person living with HS should know.
Read more
From Reactive to Proactive: Building Longitudinal Care Plans That Actually Work for Hidradenitis Suppurativa
April 17, 2026
What if dermatologic care didn’t stop at the flare? Discover why shifting from reactive treatment to proactive, longitudinal care plans can lead to better outcomes, stronger patient relationships, and management strategies that truly stand the test of time.
Read more